Search results
Roche's Lung-Cancer Drug Alecensa Gets New FDA Approval
Market Watch· 2 hours agoRoche Holding's Alecensa lung-cancer drug received a new approval from the U.S. Food and Drug Administration as an additional treatment for patients who ...
Philadelphia social worker prepares for 100-mile bike ride to support lung cancer patients
CBS News· 7 hours agoA social worker from Fox Chase will be riding 100 miles to help people with lung cancer Sunday. Lisa...
Smoking-related deaths could be reduced if people attending lung cancer screening are offered...
Medical Xpress· 1 day agoA new study has found that by offering stop-smoking support as part of the national lung cancer...
Some breast cancer patients could be at risk of another type of cancer, study reveals
Fox News· 6 days agoWomen with breast cancer who have received chemotherapy are at an increased risk of developing lung ...
Lung Cancer Study Reveals Four Microenvironment Subtypes Linked to Disease Progression
Technology Networks· 6 days agoThe team classified four different environment subtypes found around lung tumours, each associated...
Breast cancer - Latest News, Pictures, Comment and Updates | Express.co.uk
Daily Express· 1 day agoBreast cancer is a cancer that starts in the breast tissue and is the second leading cause of cancer death in women to lung& ...
Researchers discover new therapeutic target for non-small cell lung cancer
Medical Xpress· 10 hours agoNon-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment ...
Targeted therapies outperform hundreds of other drugs in 'priming' lung cancer cells for destruction
Medical Xpress· 2 days agoWhitehead Institute Valhalla Fellow Kipp Weiskopf's lab investigates how a group of immune cells...
Lifesaving tech: Lung cancer caught early with AI assist at Tavares' AdventHealth Waterman
Daily Commercial via Yahoo News· 6 days ago"It’s pretty weird because I’ve never smoked a cigarette in my life so it was a surprise, but also I...
Jefferies starts Nuvalent at buy, cites lung cancer drug candidates (NASDAQ:NUVL)
Seeking Alpha· 17 hours agoJefferies started coverage of Nuvalent (NUVL) with a buy rating, citing the company’s two lead drug...